World Journal of Endocrine Surgery

Register      Login

VOLUME 4 , ISSUE 2 ( May-August, 2012 ) > List of Articles


Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis

Yasuhiro Ito, Marko Buta, Ziv Radisavljevic, Zorka Milovanovic, Dragana Lavrnic, Igor Djurisic, Merima Oruci, Gordana Pupic, Radan Dzodic

Citation Information : Ito Y, Buta M, Radisavljevic Z, Milovanovic Z, Lavrnic D, Djurisic I, Oruci M, Pupic G, Dzodic R. Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis. World J Endoc Surg 2012; 4 (2):79-82.

DOI: 10.5005/jp-journals-10002-1102

Published Online: 01-08-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


How to cite this article

Buta M, Ito Y, Radisavljevic Z, Milovanovic Z, Lavrnic D, Djurisic I, Oruci M, Pupic G, Dzodic R. Quadruple Metachronous Malignancy in a Single Patient with Multiple Sclerosis. World J Endoc Surg 2012;4(2):79-82.

PDF Share
  1. Quadruple primary malignancies of liver, bladder, lung and stomach in one patient. Tumori 2010;96:787-91.
  2. Multiple primary malignancies including colon, stomach, lung, breast and liver cancer: A case report and literature review. Chin Med J (Engl) 2009;122:3091-93.
  3. Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 1983;33:1444.
  4. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma 2002;49:412-14.
  5. A case of quadruple primary malignancies including breast, tongue and thyroid cancers and osteosarcoma in a young female without karyotype abnormality. Breast Cancer 2011 May 12. [Epub ahead of print], available at :2048/content/1340-6868/?MUD=MPandk=tongue.
  6. A surgical case of quadruple lung cancer. Ann Thorac Cardiovasc Surg 2010;16:345-50.
  7. Quadruple malignancy in a single patient: A case report and comprehensive review of literature. J Cancer Res Ther 2010;6:230-32.
  8. A case report of quadruple cancer in a single patient including the breast, rectum, ovary and endometrium. J Gynecol Oncol 2008;19:265-69.
  9. A case of quadruple cancer including urinary bladder, oral cavity, stomach and lung. Hinyokika Kiyo 2004;50:429-33.
  10. The branchial and pharyngeal apparatus. The integumentary system. In: The developing human: Clinically oriented embryology, (5th edn). Philadelphia: WB Saunders Company 1993;186-223, 443-50.
  11. Risk of acute promyelocytic leukemia in multiple sclerosis: Coding variants of DNA repair genes. Neurology 2011;76:1059-65.
  12. Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2010;74:1463-70.
  13. Long-term risk of leukaemia or cardiomyopathy after mitoxantrone therapy for multiple sclerosis. Eur Neurol 2011;67:45-47.
  14. High incidence of synchronous or metachronous breast cancer in patients with malignant and bening thyroid tumor or tumor-like disorders. Anticancer Research 2009;29:1607-10.
  15. Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J Surg 2006;30:841-46.
  16. Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells. J Cell Biochem 2004;92:511-15.
  17. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-46.
  18. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
  19. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-22.
  20. BRCA1 and BRCA2 mutations and breast cancer. Discov Med 2011;12:445-53.
  21. Screening for wellcharacterized paraneoplastic antineuronal antibodies in multiple sclerosis. Int J Neurosci 2011;121:477-79.
  22. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3a)/ROCK kinase pathway in human breast carcinoma cells. Cancer 2003;97:1358-63.
  23. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000;275:20770-74.
  24. Locus of fragility in robust breast cancer system. J Cell Biochem 2004;92:711-15.
  25. AKT as locus of fragility in robust cancer system. J Cell Biochem 2008;104:2071-77.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.